Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

20 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Diagnosing coronary arterial stent thrombosis and arterial closure.
Hearne SE, Amsterdam PB, Baker WA, Sawchak SR, Phillips HR, Sketch MH Jr, Zidar JP. Hearne SE, et al. Among authors: sawchak sr. Am J Cardiol. 1998 Sep 1;82(5):666-8, A6. doi: 10.1016/s0002-9149(98)00387-7. Am J Cardiol. 1998. PMID: 9732898
Efficacy of xanomeline and trospium chloride in schizophrenia: pooled results from three 5-week, randomized, double-blind, placebo-controlled, EMERGENT trials.
Kaul I, Sawchak S, Claxton A, Sauder C, Hassman HH, Kakar R, Walling DP, Citrome L, Zhu H, Miller AC, Brannan SK. Kaul I, et al. Among authors: sawchak s. Schizophrenia (Heidelb). 2024 Nov 2;10(1):102. doi: 10.1038/s41537-024-00525-6. Schizophrenia (Heidelb). 2024. PMID: 39488504 Free PMC article.
Efficacy and safety of the muscarinic receptor agonist KarXT (xanomeline-trospium) in schizophrenia (EMERGENT-2) in the USA: results from a randomised, double-blind, placebo-controlled, flexible-dose phase 3 trial.
Kaul I, Sawchak S, Correll CU, Kakar R, Breier A, Zhu H, Miller AC, Paul SM, Brannan SK. Kaul I, et al. Among authors: sawchak s. Lancet. 2024 Jan 13;403(10422):160-170. doi: 10.1016/S0140-6736(23)02190-6. Epub 2023 Dec 14. Lancet. 2024. PMID: 38104575 Clinical Trial.
Clinical Trial of New Drug for Schizophrenia. Reply.
Paul SM, Breier A, Lieberman JA, Brannan SK, Sawchak S, Miller AC. Paul SM, et al. Among authors: sawchak s. N Engl J Med. 2021 Jun 24;384(25):e105. doi: 10.1056/NEJMc2104965. N Engl J Med. 2021. PMID: 34161716 No abstract available.
Rosiglitazone does not improve cognition or global function when used as adjunctive therapy to AChE inhibitors in mild-to-moderate Alzheimer's disease: two phase 3 studies.
Harrington C, Sawchak S, Chiang C, Davies J, Donovan C, Saunders AM, Irizarry M, Jeter B, Zvartau-Hind M, van Dyck CH, Gold M. Harrington C, et al. Among authors: sawchak s. Curr Alzheimer Res. 2011 Aug;8(5):592-606. doi: 10.2174/156720511796391935. Curr Alzheimer Res. 2011. PMID: 21592048 Clinical Trial.
20 results